Autonomic nervous system as a source of biomarkers in Parkinson's disease;Système nerveux autonome : Une source de biomarqueurs dans la maladie de Parkinson

Presse Medicale

Volumn 41, Issue 7-8, 2012, Pages 695-701

  Pouclet, Hélène ^a,b,c   Lebouvier, Thibaud ^a,b,c   Flamant, Mathurin ^a,b,c   Coron, Emmanuel ^a,b,c   Neunlist, Michel ^a,b,c   Derkinderen, Pascal ^a,b,c   Rouaud, Tiphaine ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; DOPA;

AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; CONSTIPATION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DYSARTHRIA; GAIT DISORDER; HUMAN; HYPOSMIA; MOTOR DYSFUNCTION; NERVE BIOPSY; PARKINSON DISEASE; PATHOPHYSIOLOGY; REM SLEEP; SHORT SURVEY; SLEEP DISORDER; SUBSTANTIA NIGRA;

AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; BIOPSY; COLON; ENTERIC NERVOUS SYSTEM; HUMANS; MODELS, BIOLOGICAL; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84862595679     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.11.018     Document Type: Short Survey

References (30)

1. Michell A.W., Lewis S.J., Foltynie T., Barker R.A. Biomarkers and Parkinson's disease. Brain 2004, 127(Pt 8):1693-1705.
2. Beach T.G., Adler C.H., Sue L.I., Vedders L., Lue L., White Iii C.L., et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2009, 119(6):689-702.
3. Braak H., Sastre M., Bohl J.R., de Vos R.A., Del Tredici K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007, 113(4):421-429.
4. Olanow C.W., Rascol O., Hauser R., Feigin P.D., Jankovic J., Lang A., et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med 2009, 361(13):1268-1278.
5. Ahlskog J.E., Uitti R.J. Rasagiline, Parkinson neuroprotection and delayed-start trials: still no satisfaction?. Neurology 2009, 74(14):1143-1148.
6. Marek K., Jennings D., Tamagnan G., Seibyl J. Biomarkers for Parkinson's (corrected) disease: tools to assess Parkinson's disease onset and progression. Ann Neurol 2008, 64(Suppl. 2):S111-S121.
7. Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009, 8(12):1150-1157.
8. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388(6645):839-840.
9. Braak H., de Vos R.A., Bohl J., Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006, 396(1):67-72.
10. Dickson D.W., Fujishiro H., Orr C., DelleDonne A., Josephs K.A., Frigerio R., et al. Neuropathology of non motor features of Parkinson disease. Parkinsonism Relat Disord 2009, 15(Suppl. 3):S1-S5.
11. Savica R., Rocca W.A., Ahlskog J.E. When does Parkinson disease start?. Arch Neurol 2010, 67(7):798-801.
12. Schemann M., Neunlist M. The human enteric nervous system. Neurogastroenterol Motil 2004, 16(Suppl. 1):55-59.
13. Braak H., Braak E., Yilmazer D., Schultz C., de Vos R.A., Jansen E.N. Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl 1995, 46:15-31.
14. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24(2):197-211.
15. Wakabayashi K., Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997, 38(Suppl. 2):2-7.
16. Lebouvier T., Tasselli M., Paillusson S., Pouclet H., Neunlist M., Derkinderen P. Biopsable neural tissues: toward new biomarkers for Parkinson's disease?. Front Psychiatry 2010, 1:128.
17. Ikemura M., Saito Y., Sengoku R., Sakiyama Y., Hatsuta H., Kanemaru K., et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008, 67(10):945-953.
18. Miki Y., Tomiyama M., Ueno T., Haga R., Nishijima H., Suzuki C., et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2009, 469(3):357-359.
19. Del Tredici K., Hawkes C.H., Ghebremedhin E., Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 2009, 119(6):703-713.
20. Cersosimo M.G., Perandones C., Micheli F.E., Raina G.B., Beron A.M., Nasswetter G., et al. Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients. Mov Disord 2011, 26(1):188-190.
21. Qualman S.J., Haupt H.M., Yang P., Hamilton S.R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984, 87(4):848-856.
22. Wakabayashi K., Takahashi H., Takeda S., Ohama E., Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988, 76(3):217-221.
23. Lebouvier T., Coron E., Chaumette T., Paillusson S., Bruley des Varannes S., Neunlist M., et al. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil 2010, 22(1):e11-e14.
24. Lebouvier T., Neunlist M., Bruley des Varannes S., Coron E., Drouard A., N'Guyen J.M., et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010, 5(9):e12728.
25. van Rooden S.M., Heiser W.J., Kok J.N., Verbaan D., van Hilten J.J., Marinus J. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010, 25(8):969-978.
26. Wakabayashi K., Takahashi H., Ohama E., Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 1990, 79(6):581-583.
27. Dafnis G., Ekbom A., Pahlman L., Blomqvist P. Complications of diagnostic and therapeutic colonoscopy within a defined population in Sweden. Gastrointest Endosc 2001, 54(3):302-309.
28. Pouclet H., Lebouvier T., Coron E., Bruley des Varannes S., Rouaud T., Roy M., et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 2010, 45(1):305-309.
29. Anderson J.P., Walker D.E., Goldstein J.M., de Laat R., Banducci K., Caccavello R.J., et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem 2006, 281(40):29739-29752.
30. Wakabayashi K., Mori F., Tanji K., Orimo S., Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 2010, 120(1):1-12.